Kiyomoto Tetsuma, Toyokawa Hideyoshi, Nakao Atsunori, Kaizu Takashi, Demetris Anthony J, Starzl Thomas E, Murase Noriko
Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USA.
Transplantation. 2006 Feb 15;81(3):438-44. doi: 10.1097/01.tp.0000188948.72706.4d.
Unequivocal eradication of donor leukocyte microchimerism from recipients of long-surviving organ transplants has never been reported. Here we describe a drastic attempt to accomplish this objective.
In control experiments, a rank order of microchimerism and of associated donor specific nonreactivity was produced in Brown-Norway (BN) rats by transplantation of Lewis (LEW) liver, bone marrow cell (BMC) and heart allografts under a brief course of tacrolimus. The degree of microchimerism at 60 and 110 days was estimated with semiquanitative immunocytochemical and PCR techniques. Tolerance at 110 days was assessed in the different control groups by challenge transplantation of naïve LEW hearts. In parallel experimental groups, an attempt was made to eliminate microchimerism from the BN recipients. The animals were submitted at 60 days to 9.5-Gy total body irradiation (TBI), reconstituted immediately with naïve BN BMC, and tested for donor specific nonreactivity by LEW heart transplantation at 110 days.
After the TBI-reconstitution at 60 days, microchimerism was undetectable in BMC recipients at 110 days, significantly reduced in heart recipients, and least affected in liver recipients. Except in liver recipients, abrogation of LEW-specific nonreactivity was demonstrated by rejection of the priming grafts, or by rejection of the challenge heart grafts, and by in vitro immune assay.
It is difficult to eliminate microchimerism in organ recipients once the donor cells have settled into tissue niches.
从未有过关于长期存活的器官移植受者体内供体白细胞微嵌合体被明确清除的报道。在此,我们描述了为实现这一目标所做的大胆尝试。
在对照实验中,通过在短期使用他克莫司的情况下移植Lewis(LEW)大鼠的肝脏、骨髓细胞(BMC)和心脏异体移植物,在Brown-Norway(BN)大鼠中产生微嵌合体及其相关的供体特异性无反应性的等级顺序。在第60天和第110天,使用半定量免疫细胞化学和PCR技术估计微嵌合体的程度。通过对未处理的LEW心脏进行挑战性移植,评估不同对照组在第110天的耐受性。在平行实验组中,尝试从BN受体中消除微嵌合体。在第60天,动物接受9.5 Gy的全身照射(TBI),立即用未处理的BN BMC进行重建,并在第110天通过LEW心脏移植测试供体特异性无反应性。
在第60天进行TBI重建后,在第110天,BMC受体中未检测到微嵌合体,心脏受体中的微嵌合体显著减少,肝脏受体中的微嵌合体受影响最小。除肝脏受体外,通过初次移植的排斥反应、挑战性心脏移植的排斥反应以及体外免疫测定,证明了LEW特异性无反应性的消除。
一旦供体细胞在组织微环境中定居,就很难在器官受体中消除微嵌合体。